Isoflavones & Lignans (so-called Phytoestrogens)
Urinary enterodiol
On this Page
Table 5.5.a. Urinary enterodiol: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
31.1 |
(28.2-34.3) |
4.35 |
(3.35-5.50) |
36.7 |
(34.2-39.4) |
173 |
(155-189) |
5321 |
6–11 years |
30.2 |
(25.1-36.5) |
5.70 |
(3.50-7.90) |
33.4 |
(28.3-39.4) |
154 |
(113-219) |
723 |
12–19 years |
32.5 |
(28.8-36.8) |
5.50 |
(4.40-6.96) |
36.8 |
(31.8-40.7) |
165 |
(134-188) |
1488 |
20–39 years |
31.2 |
(27.1-35.8) |
4.15 |
(2.50-5.70) |
37.6 |
(34.4-44.2) |
170 |
(140-197) |
1139 |
40–59 years |
31.9 |
(27.1-37.5) |
3.80 |
(1.72-6.20) |
37.7 |
(33.9-42.6) |
191 |
(167-231) |
945 |
60 years and older |
29.1 |
(25.5-33.1) |
4.20 |
(2.80-5.50) |
33.1 |
(29.3-37.6) |
163 |
(142-190) |
1026 |
Males |
Total, 6 years and older |
30.3 |
(26.8-34.2) |
3.79 |
(2.70-5.05) |
36.7 |
(33.2-40.4) |
168 |
(146-187) |
2581 |
6–11 years |
30.1 |
(24.1-37.6) |
5.70 |
(2.74-9.10) |
34.6 |
(27.0-44.1) |
132 |
(109-162) |
366 |
12–19 years |
28.6 |
(24.2-33.7) |
4.30 |
(2.70-6.94) |
32.7 |
(27.9-38.0) |
140 |
(111-186) |
729 |
20–39 years |
30.6 |
(25.9-36.0) |
3.60 |
(2.40-5.13) |
37.3 |
(32.0-46.5) |
152 |
(131-190) |
500 |
40–59 years |
32.7 |
(26.5-40.4) |
3.50 |
(<LOD-6.66) |
40.2 |
(33.8-48.4) |
207 |
(163-269) |
478 |
60 years and older |
27.0 |
(22.4-32.7) |
3.35 |
(2.00-4.47) |
33.1 |
(26.5-39.1) |
155 |
(118-197) |
508 |
Females |
Total, 6 years and older |
31.8 |
(28.9-35.1) |
5.01 |
(3.50-6.40) |
37.0 |
(34.7-39.8) |
175 |
(160-197) |
2740 |
6–11 years |
30.3 |
(23.2-39.7) |
5.85 |
(2.40-8.53) |
33.4 |
(25.6-40.2) |
174 |
(98.1-279) |
357 |
12–19 years |
37.3 |
(31.6-44.0) |
6.70 |
(5.01-8.57) |
41.7 |
(34.7-49.8) |
171 |
(148-215) |
759 |
20–39 years |
31.8 |
(27.3-37.0) |
5.30 |
(1.80-7.40) |
38.5 |
(32.8-45.7) |
180 |
(139-220) |
639 |
40–59 years |
31.1 |
(25.5-37.9) |
3.88 |
(<LOD-8.50) |
36.0 |
(30.9-41.4) |
183 |
(148-231) |
467 |
60 years and older |
30.7 |
(26.1-36.2) |
5.00 |
(2.84-7.17) |
32.8 |
(29.3-37.7) |
163 |
(139-209) |
518 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. |
Table 5.5.b. Urinary enterodiol: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
25.8 |
(23.1-28.8) |
2.76 |
(1.68-4.00) |
30.9 |
(27.5-35.2) |
146 |
(128-169) |
1470 |
6–11 years |
19.4 |
(16.0-23.6) |
< LOD |
|
22.3 |
(18.6-30.2) |
120 |
(92.6-156) |
222 |
12–19 years |
27.2 |
(22.6-32.8) |
3.80 |
(1.68-5.50) |
29.5 |
(25.4-37.8) |
159 |
(134-213) |
533 |
20–39 years |
28.6 |
(23.3-35.0) |
3.60 |
(1.60-6.50) |
34.3 |
(26.9-42.4) |
143 |
(110-202) |
300 |
40–59 years |
26.5 |
(21.5-32.6) |
2.38 |
(<LOD-6.60) |
32.4 |
(26.0-38.7) |
173 |
(141-256) |
216 |
60 years and older |
19.6 |
(15.3-25.2) |
2.13 |
(<LOD-5.40) |
23.8 |
(20.4-34.6) |
92.1 |
(74.0-143) |
199 |
Males |
Total, 6 years and older |
23.5 |
(20.0-27.6) |
2.04 |
(<LOD-3.80) |
29.5 |
(23.7-35.0) |
137 |
(105-169) |
710 |
6–11 years |
18.4 |
(15.3-22.1) |
< LOD |
|
21.3 |
(15.1-32.8) |
99.2 |
(79.2-158) |
115 |
12–19 years |
20.9 |
(16.8-26.0) |
1.68 |
(<LOD-4.53) |
24.9 |
(20.4-29.0) |
121 |
(99.9-159) |
269 |
20–39 years |
26.7 |
(19.8-36.0) |
1.84 |
(<LOD-6.30) |
30.9 |
(21.3-43.3) |
144 |
(92.5-216) |
127 |
40–59 years |
25.0 |
(18.6-33.6) |
2.36† |
(<LOD-7.70) |
33.0 |
(19.2-43.3) |
115† |
(75.9-244) |
104 |
60 years and older |
18.4 |
(12.8-26.4) |
< LOD† |
|
22.0 |
(15.7-31.9) |
73.1† |
(43.8-134) |
95 |
Females |
Total, 6 years and older |
28.5 |
(25.3-32.2) |
3.80 |
(2.21-5.74) |
33.4 |
(28.3-39.0) |
168 |
(141-192) |
760 |
6–11 years |
20.6 |
(14.6-29.0) |
2.01† |
(<LOD-5.30) |
24.2 |
(16.5-35.3) |
120† |
(92.6-219) |
107 |
12–19 years |
36.2 |
(29.2-45.0) |
5.20 |
(3.90-9.21) |
38.5 |
(29.3-51.0) |
197 |
(152-282) |
264 |
20–39 years |
31.0 |
(24.7-38.9) |
5.83 |
(<LOD-9.20) |
36.0 |
(26.9-48.1) |
132 |
(97.3-187) |
173 |
40–59 years |
28.2 |
(20.9-38.0) |
2.21 |
(<LOD-7.20) |
31.3 |
(20.0-47.2) |
197 |
(159-279) |
112 |
60 years and older |
20.7 |
(15.1-28.5) |
2.21† |
(<LOD-5.48) |
25.5 |
(16.8-37.9) |
101† |
(63.9-199) |
104 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.5.c. Urinary enterodiol: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
30.4 |
(26.5-34.9) |
4.87 |
(3.30-6.21) |
35.4 |
(31.4-38.4) |
168 |
(140-181) |
1289 |
6–11 years |
30.7 |
(26.3-35.9) |
6.64 |
(4.46-8.75) |
33.7 |
(27.5-38.7) |
132 |
(112-167) |
249 |
12–19 years |
34.9 |
(30.9-39.3) |
6.11 |
(3.56-8.33) |
41.6 |
(36.8-47.6) |
162 |
(132-213) |
451 |
20–39 years |
28.8 |
(22.0-37.7) |
5.80 |
(<LOD-8.67) |
35.3 |
(26.6-41.7) |
167 |
(115-210) |
197 |
40–59 years |
32.3 |
(25.6-40.9) |
4.54 |
(2.30-10.3) |
33.2 |
(25.7-44.9) |
207 |
(123-278) |
210 |
60 years and older |
25.7 |
(19.0-34.9) |
2.72 |
(<LOD-4.33) |
32.9 |
(24.4-40.4) |
147 |
(107-219) |
182 |
Males |
Total, 6 years and older |
25.2 |
(21.6-29.3) |
4.00 |
(1.80-5.97) |
29.9 |
(25.0-34.3) |
124 |
(104-163) |
628 |
6–11 years |
29.5 |
(23.2-37.5) |
5.80 |
(3.30-8.75) |
35.5 |
(26.2-44.5) |
129 |
(80.3-167) |
127 |
12–19 years |
30.3 |
(25.8-35.4) |
5.70 |
(3.01-8.57) |
34.6 |
(25.9-42.1) |
140 |
(119-218) |
212 |
20–39 years |
22.8 |
(16.3-32.0) |
< LOD† |
|
27.9 |
(16.6-35.3) |
107† |
(72.4-214) |
91 |
40–59 years |
25.2 |
(17.8-35.5) |
3.50† |
(<LOD-10.5) |
26.0 |
(20.0-34.9) |
123† |
(75.8-227) |
109 |
60 years and older |
20.3 |
(14.8-28.0) |
< LOD† |
|
29.1 |
(19.3-38.0) |
96.3† |
(65.0-143) |
89 |
Females |
Total, 6 years and older |
35.8 |
(29.9-42.9) |
5.50 |
(3.30-8.70) |
41.7 |
(35.4-47.0) |
180 |
(154-237) |
661 |
6–11 years |
32.1 |
(25.6-40.2) |
7.34 |
(4.00-11.4) |
33.7 |
(27.2-38.8) |
137 |
(92.6-230) |
122 |
12–19 years |
40.2 |
(33.4-48.4) |
6.13 |
(3.20-12.0) |
47.0 |
(38.7-59.2) |
171 |
(125-247) |
239 |
20–39 years |
34.7 |
(24.7-48.8) |
7.80† |
(<LOD-10.6) |
41.7 |
(32.5-50.4) |
176† |
(115-237) |
106 |
40–59 years |
40.0 |
(28.9-55.4) |
5.50† |
(2.30-13.1) |
37.8 |
(25.9-63.7) |
250† |
(144-340) |
101 |
60 years and older |
30.1 |
(18.5-48.8) |
2.80† |
(<LOD-6.25) |
36.3 |
(22.5-49.2) |
172† |
(123-396) |
93 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.5.d. Urinary enterodiol: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
32.4 |
(29.3-35.8) |
4.68 |
(3.50-5.90) |
38.5 |
(36.0-41.7) |
173 |
(152-195) |
2110 |
6–11 years |
32.5 |
(24.6-42.8) |
5.90 |
(2.40-10.5) |
35.7 |
(28.1-44.8) |
152 |
(106-253) |
196 |
12–19 years |
32.7 |
(27.6-38.7) |
6.10 |
(3.97-7.80) |
35.4 |
(29.7-43.8) |
162 |
(127-185) |
375 |
20–39 years |
33.4 |
(28.3-39.5) |
4.70 |
(2.70-6.10) |
43.1 |
(37.4-47.1) |
174 |
(138-214) |
529 |
40–59 years |
33.2 |
(27.3-40.4) |
3.80 |
(<LOD-7.40) |
40.5 |
(35.8-46.7) |
207 |
(158-254) |
433 |
60 years and older |
29.6 |
(25.7-34.1) |
4.35 |
(2.74-6.10) |
33.4 |
(29.7-38.7) |
160 |
(139-190) |
577 |
Males |
Total, 6 years and older |
32.7 |
(28.6-37.4) |
4.20 |
(2.92-5.56) |
40.0 |
(35.4-44.1) |
174 |
(146-198) |
1036 |
6–11 years |
33.7 |
(24.0-47.3) |
7.55† |
(<LOD-14.6) |
37.8 |
(25.7-50.9) |
135† |
(103-215) |
101 |
12–19 years |
28.6 |
(22.9-35.7) |
4.30 |
(2.38-7.80) |
32.5 |
(24.3-40.7) |
131 |
(99.1-174) |
190 |
20–39 years |
33.9 |
(27.3-42.2) |
3.79 |
(<LOD-5.95) |
44.2 |
(34.9-55.1) |
174 |
(132-226) |
231 |
40–59 years |
35.9 |
(28.1-46.0) |
3.65 |
(<LOD-7.40) |
46.7 |
(37.8-53.2) |
213 |
(167-263) |
224 |
60 years and older |
28.1 |
(22.8-34.7) |
3.35 |
(2.00-5.30) |
33.2 |
(26.5-40.0) |
163 |
(120-205) |
290 |
Females |
Total, 6 years and older |
32.1 |
(29.0-35.6) |
5.35 |
(3.53-6.70) |
37.6 |
(35.0-41.1) |
171 |
(148-209) |
1074 |
6–11 years |
31.2 |
(20.5-47.7) |
5.85† |
(<LOD-12.2) |
34.1 |
(22.3-50.8) |
174† |
(87.0-327) |
95 |
12–19 years |
38.0 |
(29.5-48.9) |
6.87 |
(3.97-11.2) |
43.5 |
(29.3-58.0) |
170 |
(144-245) |
185 |
20–39 years |
33.0 |
(26.9-40.4) |
5.70 |
(1.80-7.60) |
41.1 |
(30.1-47.8) |
166 |
(130-220) |
298 |
40–59 years |
30.8 |
(24.1-39.4) |
4.09 |
(<LOD-10.4) |
36.2 |
(27.8-42.5) |
195 |
(127-259) |
209 |
60 years and older |
30.8 |
(25.6-37.2) |
5.18 |
(2.74-7.50) |
32.9 |
(29.2-39.8) |
160 |
(127-209) |
287 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Urinary enterodiol (creatinine corrected)
Table 5.5.e. Urinary enterodiol: Total population (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
29.0 |
(26.5-31.7) |
4.17 |
(3.19-5.13) |
33.6 |
(31.1-36.8) |
150 |
(136-163) |
5321 |
6–11 years |
32.8 |
(27.6-39.0) |
5.61 |
(3.48-7.95) |
36.2 |
(30.8-42.7) |
188 |
(140-244) |
723 |
12–19 years |
23.5 |
(21.1-26.3) |
4.27 |
(2.64-5.42) |
26.6 |
(24.1-30.4) |
102 |
(93.2-117) |
1488 |
20–39 years |
25.0 |
(21.6-28.9) |
3.52 |
(2.52-5.12) |
28.2 |
(25.3-32.7) |
124 |
(108-156) |
1139 |
40–59 years |
32.0 |
(27.7-36.9) |
3.50 |
(2.54-5.86) |
39.1 |
(33.2-44.8) |
162 |
(140-197) |
945 |
60 years and older |
34.9 |
(31.1-39.2) |
5.13 |
(4.30-7.13) |
41.3 |
(35.6-46.2) |
174 |
(157-194) |
1026 |
Males |
Total, 6 years and older |
24.3 |
(21.7-27.4) |
3.17 |
(2.52-4.34) |
28.8 |
(25.2-31.7) |
129 |
(111-152) |
2581 |
6–11 years |
31.8 |
(25.1-40.2) |
4.62 |
(2.80-8.38) |
34.8 |
(28.3-43.7) |
172 |
(112-244) |
366 |
12–19 years |
20.3 |
(17.2-23.9) |
3.27 |
(1.98-4.96) |
23.9 |
(20.5-28.1) |
94.1 |
(81.5-111) |
729 |
20–39 years |
21.3 |
(18.3-24.8) |
2.84 |
(2.15-4.03) |
24.6 |
(21.2-28.1) |
111 |
(96.4-130) |
500 |
40–59 years |
27.2 |
(22.4-33.0) |
3.19 |
(<LOD-5.80) |
31.7 |
(28.3-41.9) |
160 |
(121-201) |
478 |
60 years and older |
25.5 |
(20.5-31.7) |
2.96 |
(2.04-4.74) |
30.2 |
(23.8-35.4) |
138 |
(105-179) |
508 |
Females |
Total, 6 years and older |
34.2 |
(31.2-37.5) |
5.26 |
(4.20-7.08) |
39.9 |
(36.6-43.8) |
162 |
(148-178) |
2740 |
6–11 years |
33.9 |
(26.8-42.8) |
6.64 |
(3.93-8.55) |
37.3 |
(28.6-50.1) |
193 |
(108-304) |
357 |
12–19 years |
27.5 |
(24.0-31.5) |
5.26 |
(3.66-7.26) |
30.0 |
(26.2-34.9) |
115 |
(100-132) |
759 |
20–39 years |
29.2 |
(24.7-34.6) |
4.73 |
(2.54-7.41) |
33.5 |
(28.1-40.6) |
141 |
(108-182) |
639 |
40–59 years |
37.3 |
(31.0-44.9) |
4.11 |
(<LOD-9.07) |
44.6 |
(39.0-53.0) |
165 |
(140-217) |
467 |
60 years and older |
44.4 |
(38.2-51.7) |
7.53 |
(5.23-12.3) |
51.4 |
(44.8-58.8) |
188 |
(164-222) |
518 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD. |
Table 5.5.f. Urinary enterodiol: Mexican Americans (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
23.8 |
(21.5-26.3) |
3.21 |
(2.34-4.32) |
27.6 |
(25.2-30.2) |
134 |
(116-158) |
1470 |
6–11 years |
24.8 |
(20.1-30.6) |
< LOD |
|
32.4 |
(23.9-40.2) |
140 |
(105-182) |
222 |
12–19 years |
21.7 |
(18.2-25.7) |
3.35 |
(1.53-5.17) |
23.9 |
(19.0-30.4) |
115 |
(99.3-134) |
533 |
20–39 years |
23.6 |
(19.5-28.6) |
2.78 |
(1.62-5.36) |
27.1 |
(22.4-30.1) |
127 |
(91.4-181) |
300 |
40–59 years |
26.0 |
(21.3-31.6) |
4.20 |
(<LOD-6.80) |
30.6 |
(21.5-42.2) |
157 |
(126-192) |
216 |
60 years and older |
22.7 |
(17.8-28.9) |
2.26 |
(<LOD-7.79) |
31.3 |
(25.7-38.1) |
110 |
(80.0-149) |
199 |
Males |
Total, 6 years and older |
19.4 |
(16.9-22.2) |
2.48 |
(<LOD-4.32) |
21.9 |
(18.9-26.1) |
117 |
(87.5-141) |
710 |
6–11 years |
21.9 |
(17.5-27.5) |
< LOD |
|
26.9 |
(19.9-39.3) |
129 |
(83.7-188) |
115 |
12–19 years |
15.9 |
(12.6-20.2) |
1.99 |
(<LOD-3.66) |
18.3 |
(15.2-22.5) |
85.9 |
(73.8-115) |
269 |
20–39 years |
19.6 |
(14.9-25.9) |
2.34 |
(<LOD-5.83) |
20.0 |
(15.7-27.8) |
117 |
(82.1-179) |
127 |
40–59 years |
20.9 |
(15.9-27.5) |
4.92† |
(<LOD-6.91) |
23.5 |
(13.6-36.6) |
120† |
(59.6-192) |
104 |
60 years and older |
17.5 |
(12.0-25.7) |
< LOD† |
|
22.7 |
(17.0-36.2) |
74.3† |
(49.3-179) |
95 |
Females |
Total, 6 years and older |
29.8 |
(26.5-33.6) |
4.68 |
(2.71-7.01) |
34.4 |
(29.6-38.8) |
154 |
(127-193) |
760 |
6–11 years |
28.1 |
(20.5-38.7) |
2.82† |
(<LOD-6.25) |
37.3 |
(25.1-48.1) |
144† |
(98.7-279) |
107 |
12–19 years |
30.3 |
(25.3-36.3) |
6.40 |
(3.13-9.44) |
31.6 |
(24.0-43.4) |
156 |
(112-195) |
264 |
20–39 years |
29.3 |
(23.8-36.0) |
5.23 |
(<LOD-9.41) |
31.0 |
(27.1-38.8) |
133 |
(93.6-193) |
173 |
40–59 years |
32.7 |
(24.9-43.0) |
4.56 |
(<LOD-10.1) |
44.8 |
(27.0-59.4) |
183 |
(141-235) |
112 |
60 years and older |
28.2 |
(20.3-39.3) |
3.80† |
(<LOD-8.93) |
34.5 |
(28.6-42.2) |
130† |
(78.9-213) |
104 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.5.g. Urinary enterodiol: Non-Hispanic blacks (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
20.5 |
(17.5-24.0) |
3.30 |
(2.47-4.03) |
23.3 |
(19.7-26.6) |
118 |
(97.4-138) |
1289 |
6–11 years |
28.7 |
(24.0-34.4) |
5.03 |
(4.02-7.59) |
31.1 |
(26.1-38.8) |
126 |
(95.2-168) |
249 |
12–19 years |
19.6 |
(17.2-22.3) |
3.48 |
(2.11-4.47) |
23.5 |
(19.7-27.2) |
86.8 |
(72.7-116) |
451 |
20–39 years |
16.4 |
(12.2-22.0) |
2.15 |
(<LOD-4.41) |
19.3 |
(14.1-23.8) |
96.0 |
(68.6-128) |
197 |
40–59 years |
21.8 |
(16.9-28.2) |
3.57 |
(2.35-5.11) |
23.3 |
(16.2-31.4) |
145 |
(94.5-187) |
210 |
60 years and older |
24.2 |
(17.8-32.8) |
2.94 |
(<LOD-5.25) |
27.0 |
(22.7-38.6) |
146 |
(88.0-241) |
182 |
Males |
Total, 6 years and older |
15.2 |
(12.9-18.0) |
2.40 |
(1.44-3.12) |
18.0 |
(14.6-21.0) |
84.6 |
(65.9-108) |
628 |
6–11 years |
27.3 |
(20.5-36.4) |
4.14 |
(2.52-9.49) |
30.8 |
(25.6-42.5) |
106 |
(77.7-168) |
127 |
12–19 years |
16.5 |
(14.0-19.5) |
2.23 |
(1.22-4.05) |
20.0 |
(15.1-24.3) |
82.9 |
(61.4-103) |
212 |
20–39 years |
11.1 |
(7.62-16.1) |
< LOD† |
|
12.9 |
(10.3-18.0) |
70.4† |
(30.6-154) |
91 |
40–59 years |
15.3 |
(11.1-21.3) |
2.65† |
(<LOD-5.24) |
15.9 |
(12.8-21.0) |
72.6† |
(41.9-155) |
109 |
60 years and older |
15.1 |
(11.2-20.4) |
< LOD† |
|
24.0 |
(13.9-30.2) |
66.1† |
(45.5-97.2) |
89 |
Females |
Total, 6 years and older |
26.5 |
(21.6-32.5) |
4.41 |
(3.40-5.50) |
30.1 |
(23.5-37.7) |
138 |
(112-180) |
661 |
6–11 years |
30.3 |
(24.4-37.7) |
6.64 |
(4.20-8.88) |
33.8 |
(23.2-41.8) |
134 |
(93.9-209) |
122 |
12–19 years |
23.2 |
(19.3-28.0) |
3.96 |
(2.30-6.55) |
26.2 |
(22.6-30.0) |
106 |
(71.7-145) |
239 |
20–39 years |
22.4 |
(15.8-31.8) |
4.87† |
(<LOD-7.83) |
26.6 |
(18.2-41.9) |
99.4† |
(68.6-138) |
106 |
40–59 years |
29.4 |
(20.0-43.3) |
4.32† |
(2.35-8.07) |
34.8 |
(22.6-48.1) |
158† |
(118-321) |
101 |
60 years and older |
33.0 |
(20.2-53.7) |
3.35† |
(<LOD-9.66) |
33.3 |
(22.7-54.5) |
229† |
(123-590) |
93 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.5.h. Urinary enterodiol: Non-Hispanic whites (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
32.3 |
(29.5-35.3) |
5.15 |
(3.94-6.23) |
37.4 |
(33.7-41.4) |
158 |
(140-174) |
2110 |
6–11 years |
35.3 |
(27.5-45.2) |
6.62 |
(3.23-9.63) |
40.3 |
(29.4-50.4) |
188 |
(132-281) |
196 |
12–19 years |
24.8 |
(21.2-29.0) |
5.02 |
(2.36-7.01) |
28.1 |
(24.3-33.6) |
99.5 |
(91.3-121) |
375 |
20–39 years |
29.1 |
(24.9-34.2) |
4.84 |
(2.92-6.99) |
31.3 |
(27.2-37.6) |
140 |
(109-182) |
529 |
40–59 years |
34.9 |
(29.3-41.5) |
3.68 |
(<LOD-7.14) |
43.4 |
(37.7-52.9) |
165 |
(135-208) |
433 |
60 years and older |
37.0 |
(32.4-42.2) |
5.89 |
(4.17-7.67) |
44.0 |
(36.7-50.3) |
179 |
(155-209) |
577 |
Males |
Total, 6 years and older |
27.7 |
(24.5-31.3) |
3.53 |
(2.80-5.38) |
31.9 |
(28.0-36.9) |
138 |
(114-170) |
1036 |
6–11 years |
37.0 |
(25.9-52.8) |
6.62† |
(<LOD-14.2) |
42.2 |
(21.7-60.2) |
202† |
(105-290) |
101 |
12–19 years |
21.7 |
(17.2-27.5) |
4.74 |
(1.98-6.23) |
24.7 |
(20.8-33.1) |
94.1 |
(71.7-119) |
190 |
20–39 years |
25.8 |
(21.2-31.4) |
3.41 |
(<LOD-6.26) |
28.0 |
(24.0-34.9) |
121 |
(100-167) |
231 |
40–59 years |
30.2 |
(24.4-37.5) |
3.13 |
(<LOD-6.83) |
38.0 |
(30.0-51.0) |
160 |
(114-216) |
224 |
60 years and older |
27.0 |
(21.1-34.5) |
3.19 |
(2.17-5.13) |
31.1 |
(23.8-40.0) |
138 |
(104-189) |
290 |
Females |
Total, 6 years and older |
37.4 |
(34.2-40.9) |
7.08 |
(4.81-7.92) |
43.1 |
(38.7-48.7) |
168 |
(151-196) |
1074 |
6–11 years |
33.4 |
(23.1-48.3) |
6.28† |
(<LOD-10.0) |
35.5 |
(27.5-60.6) |
150† |
(87.0-325) |
95 |
12–19 years |
28.7 |
(23.3-35.3) |
6.14 |
(3.02-7.64) |
32.1 |
(26.2-38.8) |
112 |
(90.2-146) |
185 |
20–39 years |
32.8 |
(27.1-39.8) |
6.46 |
(3.12-10.7) |
34.9 |
(27.8-47.5) |
166 |
(107-235) |
298 |
40–59 years |
40.1 |
(32.3-49.8) |
6.00 |
(<LOD-14.4) |
48.7 |
(39.0-58.5) |
165 |
(129-224) |
209 |
60 years and older |
47.2 |
(39.4-56.7) |
8.54 |
(6.23-14.9) |
53.0 |
(46.4-65.3) |
189 |
(157-225) |
287 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |